May 20, 2022 ST. LOUIS, Mo. — The Global Myopia Awareness Coalition (GMAC) announced the appointment of its Board for 2022, including...
May 25, 2021 BRIDGEWATER, NJ — Nevakar has launched Vyluma, a new company that will create treatments for ophthalmic diseases such as...
April 12, 2021 CLICK HERE to view the presentation after April 29, 2021. The Ophthalmology Innovation Summit (OIS) will host a virtual...
February 1, 2021 BRIDGEWATER, N.J. and Clermont-Ferrand, France – Nevakar Inc. and Laboratoires Théa entered an exclusive licensing agreement for the commercialization...
November 12, 2020 The number of Americans who are nearsighted has nearly doubled over the last 50 years to 41.6 percent. This...
November 9, 2020 Nevakar Inc., a biopharmaceutical company developing multiple products in the ophthalmic and injectable areas, announced today that the first...
November 1, 2020 By Thomas Aller, OD, FBCLA Collaborator, BHVI With the increasing incidence of myopia all around the world, predictions of...
October 7, 2020 In support of the October 8 World Sight Day, an annual day of awareness to focus global attention on...
May 5, 2020 MyMyopia is a disease awareness effort that shares important information with parents and eye care professionals on the growing...
Myopia progression is irreversible, so when this treatment window closes, the higher risk of vision loss remains for life.
Tens of millions of myopic children around the world need our help.
Jobson Medical Information will be the official North American media sponsor.
Jobson Optical Research, sponsored by Essilor, polled more than 300 optometrists in the U.S.